HCW Biologics Analyst Price Targets

Wall Street analyst price targets and consensus rating for HCW Biologics (HCWB).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$30Upside to Avg. PT+1750.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 28, 2026	Maxim Group	Michael Okunewitch	PT Raise	Buy	$2→$5
May 29, 2025	Maxim Group	Michael Okunewitch	PT Cut	Buy	$120→$35

Analyst Ratings News

PRO
Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and raises the price target from $2 to $5.

Benzinga Newsdesk

PRO
Maxim Group Maintains Buy on HCW Biologics, Lowers Price Target to $35

Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and lowers the price target from $120 to $35.

Benzinga Newsdesk

PRO
EF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

EF Hutton analyst Tony Butler assumes HCW Biologics (NASDAQ:HCWB) with a Buy rating and announces Price Target of $9.

Benzinga Newsdesk

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

EF Hutton analyst Constantine Davides reiterates HCW Biologics (NASDAQ:HCWB) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

EF Hutton analyst Constantine Davides reiterates HCW Biologics (NASDAQ:HCWB) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

EF Hutton analyst Constantine Davides reiterates HCW Biologics (NASDAQ:HCWB) with a Buy and maintains $9 price target.

Benzinga Newsdesk

HCW Biologics Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

HCW Biologics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

PRO
Maxim Group Maintains Buy on HCW Biologics, Lowers Price Target to $35

PRO
EF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

People Also Watch

People Also Watch

HCW Biologics Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

HCW Biologics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMaxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

PROMaxim Group Maintains Buy on HCW Biologics, Lowers Price Target to $35

PROEF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

PROEF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PROEF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PROEF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

People Also Watch

People Also Watch

PRO
Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

PRO
Maxim Group Maintains Buy on HCW Biologics, Lowers Price Target to $35

PRO
EF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target